A major 72-week trial shows tirzepatide leads to double-digit weight loss and greater waist reduction than semaglutide ... practice rather than a fixed-dose protocol. Among the 750 enrolled ...

“If you lose weight too fast, the excess skin is going to be a bigger problem, but also once you get to a certain age, even ...

Wegovy is a semaglutide drug approved ... as opposed to the once-a-week protocol for injectable GLP-1 medications. Nonetheless, experts said oral forms of weight loss medication may still be ...

The Subject Expert Committee (SEC) on Endocrinology and Metabolism, operating under the Central Drugs Standard Control ...

Growing At-Home Men's Health Program in North America-PeterMD's Telemedicine Clinic Offers Transparent, Doctor-Supervised TRT ...

A study, which was published in The New England Journal of Medicine, found that tirzepatide (Zepbound) is more effective for ...

Scientists found brain cells behind semaglutide’s weight-loss power—and they don’t cause the nasty side effects.

A study from the University of Gothenburg identifies specific brain neurons controlling semaglutide's weight loss effects.

The researchers found that after 64 weeks, participants had a mean weight loss of −16.7%, with a mean semaglutide dose of 1.08mg/week.

Among patients who experienced an early cardiovascular event, those treated with semaglutide had approximately 40% fewer ...